DPP4, dipeptidyl peptidase 4, 1803

N. diseases: 451; N. variants: 13
Disease: Macroangiopathy ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1096293
Disease: Macroangiopathy
Macroangiopathy 		0.010 Biomarker disease BEFREE We purpose to confirm the effect of teneligliptin (Tenelia), a selective dipeptidyl peptidase-4 (DPP-4) inhibitor, on glycemic control and non-glucose risk factors for macroangiopathy, including blood pressure, lipid metabolism, and body weight. 30974980 2020